Human Organic Cation Transporter 1 Protein Levels of Granulocytes Can Optimize Imatinib Therapy in Patients with Chronic Myeloid Leukemia

Publisher： Karger

E-ISSN： 1421-9662|133|2|199-204

ISSN： 0001-5792

Source： Acta Haematologica, Vol.133, Iss.2, 2014-10, pp. : 199-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nilotinib Can Override Dasatinib Resistance in Chronic Myeloid Leukemia Patients with Secondary Resistance to Imatinib First-Line Therapy

By  

Acta Haematologica, Vol. 118, Iss. 3, 2007-09 ,pp. : 162-164

Karger

Access to resources Recommend Favorite

BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia

By Jönsson Sofia   Olsson Bob   Jacobsson Stefan   Palmqvist Lars   Ricksten Anne   Ekeland-Sjöberg Kerstin   Wadenvik Hans  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 71, Iss. 1, 2011-02 ,pp. : 7-11

Informa Healthcare

Access to resources Recommend Favorite

Imatinib Mesylate Therapy Induces Reduction in Neutrophil Gelatinase-Associated Lipocalin Serum Levels and Increase in Leptin Concentrations in Chronic Myeloid Leukemia Patients in Molecular Remission

By  

Acta Haematologica, Vol. 127, Iss. 1, 2011-10 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Apoptosis-Related Gene Expression Profile in Chronic Myeloid Leukemia Patients after Imatinib Mesylate and Dasatinib Therapy

By  

Acta Haematologica, Vol. 133, Iss. 4, 2015-02 ,pp. : 354-364

Karger

Access to resources Recommend Favorite

Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy

By  

Acta Haematologica, Vol. 137, Iss. 3, 2017-04 ,pp. : 158-162

Karger

Access to resources Recommend Favorite